shortagewatch

Home / Nervous system / Cabergoline

ATC N04BC06 · Dopamine Agonists

Cabergoline shortage

As of 2 Nov 2026, Cabergoline has a reported shortage in 3 of the 16 countries we track (Germany, Spain, Australia), covering 7 products from 2 companies.

Countries3/16
Products7packs or presentations
Companies22 listed
Short since1 Jun 20265 months ago
Earliest return6 Nov 2026company estimate
Main reasonActive ingredient shortage
United StatesNo reported shortageCanadaNo reported shortageGermany4 products shortFranceNo reported shortageItalyNo reported shortageSpain1 product shortIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageNew ZealandNo reported shortageAustralia2 products short

Timeline

GermanySpainAustralia
2027Cabaseril 1 mgCabaseril 1 mgCabaseril 1 mgCabaseril 1 mgCabaseril 2 mgCabaseril 2 mgCabaseril 2 mgCabaseril 2 mgCABERGOLINA TEVA 1 mg COMPRIMIDOS EFG , 20 cCABERGOLINA TEVA 1 mg COMPRIMIDOS EFG , 20 comprimidosCABASER Cabergoline 1mg tablet bottleCABASER Cabergoline 1mg tablet bottleCABASER Cabergoline 2mg tablet bottleCABASER Cabergoline 2mg tablet bottletoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Pfizer4 PFETeva1 TEVA

Listed: Pfizer PFE · NYSE, Teva TEVA · NYSE / TASE

Compared with similar medicines

ATC group N04BC · Dopamine Agonists
Ropinirole8/16Pramipexole6/16Cabergoline3/16Apomorphine2/16Bromocriptine2/16

Affected products

CountryProductCompanySinceExpected backReason
DECabaseril 1 mgPfizer Pharma GmbH1 Jun 202615 Dec 2026Active ingredient shortage
Probleme beim Wirkstoffhersteller
DECabaseril 1 mgPfizer Pharma GmbH1 Jun 202615 Dec 2026Active ingredient shortage
Probleme beim Wirkstoffhersteller
DECabaseril 2 mgPfizer Pharma GmbH1 Jun 202615 Dec 2026Active ingredient shortage
Probleme beim Wirkstoffhersteller
DECabaseril 2 mgPfizer Pharma GmbH1 Jun 202615 Dec 2026Active ingredient shortage
Probleme beim Wirkstoffhersteller
ESCABERGOLINA TEVA 1 mg COMPRIMIDOS EFG , 20 comprimidosTeva Gmbh23 Aug 202619 Nov 2026Not stated
AUCABASER Cabergoline 1mg tablet bottle25 Jun 20266 Nov 2026Not stated
AUCABASER Cabergoline 2mg tablet bottle limited25 Jun 20266 Nov 2026Not stated

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.